Clinical Trial Collaborations Speakers
Bennett Levitan, MD, PhD
Senior Director, Benefit-risk Assessment, Department of Epidemiology
Janssen R&D, LLC
Bennett Levitan, MD, PhD is Director, Epidemiology at Janssen R&D. He is responsible for enabling teams to develop benefit-risk assessments for FDA, EMA and other health authorities. He has over 20 years’ experience in decision analysis, modeling and simulation. Bennett co-led technical development of the PhRMA Benefit Risk Action Team (BRAT) Framework for drug benefit-risk assessment. He serves on several PhRMA committees that influence policy in this field and is a member of the Next Steps Working Group, the Centre for Innovation in Regulatory Science Benefit-risk Task Force, the ISPE Benefit Risk Assessment Special Interest Group and the Medical Device Innovation Consortium Patient Center Benefit/Risk Project Steering Committee. Bennett received his BSc (Electrical Engineering) from Columbia University in New York and his MD, PhD (Bioengineering) from the University of Pennsylvania.